Nonsteroidal anti-inflammatory drugs may give some protection against esophageal adenocarcinoma developing from its premalignant state, Barrett's esophagus.Genetic abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma and Barrett's esophagus. [click link for full article]